GalenicaGALNF 81 Buyback Yield % is 0.19 as of Jul. 02, 2026. GuruFocus rates GALNF with a GF Score™ of 81/100 and a GF Value™ of $115.34. The stock has 1 warning sign investors should review. Among 40 Medical Distribution companies, Galenica ranks better than 57.5% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Galenica's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GALNF vs MCK, CAH, COR: Buyback Yield % Comparison
For the Medical Distribution subindustry, Galenica's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Galenica Buyback Yield % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Galenica's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Galenica's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Galenica (GALNF) has a Buyback Yield % of 0.19 as of Jul. 02, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Galenica and its competitors. According to the industry distribution chart, Galenica ranks #17 out of 40 companies in the Medical Distribution industry, placing it in the top 42.5%.
Is Galenica's Buyback Yield % too high?
Galenica's current Buyback Yield % is 0.19. The Medical Distribution industry median Buyback Yield % is 0.02. Galenica's value of 0.19 is 850% above this industry median. Based on the distribution chart, Galenica ranks #17 out of 40 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Galenica has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Galenica's Buyback Yield % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Galenica ranks #17 out of 40 companies for Buyback Yield %. This puts Galenica in the upper half of its industry. The industry median Buyback Yield % is 0.02. Galenica's value of 0.19 is 850% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Distribution company?
The median Buyback Yield % among Medical Distribution companies is 0.02, based on 40 companies in the industry. Companies in the top quartile (top 25%) have a Buyback Yield % significantly above this median, while those in the bottom quartile fall well below. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Galenica's current Buyback Yield % of 0.19 is 850% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Galenica and its competitors. For the Medical Distribution industry, the median Buyback Yield % is 0.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Galenica's current Buyback Yield % is 0.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Galenica stock overvalued right now?
Galenica (GALNF) has a current Buyback Yield % of 0.19. The stock's GF Value™ is $115.34, compared to a current price of $115.00 — trading 0.3% below its estimated fair value. The current Buyback Yield % is 0.19 and 850% above the Medical Distribution industry median of 0.02. Galenica's overall GF Score™ is 81/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Galenica (GALNF), the current Buyback Yield % is 0.19 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Galenica (GALNF) Overvalued in 2026?
Based on GuruFocus' analysis, Galenica stock appears to be undervalued.
The current stock price of $115.00 is trading 0.3% below its estimated GF Value™ of $115.34.
Key valuation signals for GALNF:
Buyback Yield %: 0.19
GF Value™: $115.34 vs. price of $115.00 (0.3% below fair value)
Industry Position: 850% above the Medical Distribution median (#17 of 40)
No single metric tells the full story. See the GALNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Galenica Ltd is an integrated healthcare service provider in Switzerland. The business is operated from two segments Products & Care and Logistics & IT. The Products & Care segment comprises the Retail business area with offerings for patients and end customers and the Professionals business area with offerings for business customers and partners in the healthcare sector. The Logistics & IT segment comprises the two sectors Wholesale and Logistics & IT Services. These provide services for all those involved in the healthcare sector - pharmacies, drugstores, doctors, hospitals and care homes, partners, and suppliers. Geographically, it operates in Switzerland and Other Countries.
81GF Score
Get the complete analysis for GALNF
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GALNF has been successfully added to your 
